Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.

Authors

• Glen E D'Souza
• Uche Nwagu
• Blair Barton
• Aykut A Unsal
• Mindy R Rabinowitz
• Marc R Rosen
• Gurston G Nyquist
• John Cohn
• Jessica Most
• Elina M Toskala

Publication/Presentation Date

3-1-2022

Volume

12

Issue

3

First Page

306

Last Page

309

ISSN

2042-6984

Published In/Presented At

D'Souza, G. E., Nwagu, U., Barton, B., Unsal, A. A., Rabinowitz, M. R., Rosen, M. R., Nyquist, G. G., Cohn, J., Most, J., & Toskala, E. M. (2022). Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics. International forum of allergy & rhinology, 12(3), 306–309. https://doi.org/10.1002/alr.22900

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

34719120

Department(s)

Administration and Leadership

Document Type

Article